MINISYMPOSIUM PROGRAM
Conjoint 538, Winter 2004

 

 

TUESDAY, FEBRUARY 3, 8:30 AM

Session I

 

RAD51 --- Josh Veatch

Henry-Mowatt, J., Jackson, D., Masson, J. Y., Johnson, P. A., Clements, P. M., Benson, F. E., Thompson, L. H., Takeda, S., West, S. C., and Caldecott, K. W. (2003). XRCC3 and Rad51 modulate replication fork progression on damaged vertebrate chromosomes. Mol Cell 11, 1109-1117.

 

RAD52/54 --Roland Walter

Essers, J., Houtsmuller, A. B., van Veelen, L., Paulusma, C., Nigg, A. L., Pastink, A., Vermeulen, W., Hoeijmakers, J. H., and Kanaar, R. (2002). Nuclear dynamics of RAD52 group homologous recombination proteins in response to DNA damage. Embo J 21, 2030-2037.

 

BRCA1 --- Qiangwei Xia

Dong, Y., Hakimi, M. A., Chen, X., Kumaraswamy, E., Cooch, N. S., Godwin, A. K., and Shiekhattar, R. (2003). Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol Cell 12, 1087-1099.

 

BRCA2 --- Meredith Mathis

Pellegrini, L., Yu, D. S., Lo, T., Anand, S., Lee, M., Blundell, T. L., and Venkitaraman, A. R. (2002). Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nature 420, 287-293.

 

FANC---Shinji Kasahara

Levitus, M., Rooimans, M. A., Steltenpool, J., Cool, N. F., Oostra, A. B., Mathew, C. G., Hoatlin, M. E., Waisfisz, Q., Arwert, F., De Winter, J. P., and Joenje, H. (2003). Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood.

 

FANC D --- Jenn Pang

Houghtaling, S., Timmers, C., Noll, M., Finegold, M. J., Jones, S. N., Meyn, M. S., and Grompe, M. (2003). Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev 17, 2021-2035.

 

XRCC1 ---  Carol Holman 

Whitehouse, C. J., Taylor, R. M., Thistlethwaite, A., Zhang, H., Karimi-Busheri, F., Lasko, D. D., Weinfeld, M., and Caldecott, K. W. (2001). XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 104, 107-117.

           

 

 

THURSDAY, FEBRUARY 5, 8:30 AM

Session II

 

MUS81/EME1 --- Nicolle Hamilton

Abraham, J., Lemmers, B., Hande, M. P., Moynahan, M. E., Chahwan, C., Ciccia, A., Essers, J., Hanada, K., Chahwan, R., Khaw, A. K., et al. (2003). Eme1 is involved in DNA damage processing and maintenance of genomic stability in mammalian cells. Embo J 22, 6137-6147.

 

WRN --- Joe Rogers

Baynton, K., Otterlei, M., Bjoras, M., von Kobbe, C., Bohr, V. A., and Seeberg, E. (2003). WRN interacts physically and functionally with the recombination mediator protein RAD52. J Biol Chem 278, 36476-36486.

 

BLM --- Steve Reynolds

Wu, L., and Hickson, I. D. (2003). The Bloom's syndrome helicase suppresses crossing over during homologous recombination. Nature 426, 870-874.

 

Ku/DNA-PK/Artemis  --- Dawn Harris

Karanjawala, Z. E., Adachi, N., Irvine, R. A., Oh, E. K., Shibata, D., Schwarz, K., Hsieh, C. L., and Lieber, M. R. (2002). The embryonic lethality in DNA ligase IV-deficient mice is rescued by deletion of Ku: implications for unifying the heterogeneous phenotypes of NHEJ mutants. DNA Repair (Amst) 1, 1017-1026.

 

DNA LIGASE 4   --- Ryan Roper

Frank, K. M., Sharpless, N. E., Gao, Y., Sekiguchi, J. M., Ferguson, D. O., Zhu, C., Manis, J. P., Horner, J., DePinho, R. A., and Alt, F. W. (2000). DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol Cell 5, 993-1002.

 

RAG1/2 --- Colin Havenar-Daughton

Messier, T. L., O'Neill, J. P., Hou, S. M., Nicklas, J. A., and Finette, B. A. (2003). In vivo transposition mediated by V(D)J recombinase in human T lymphocytes. Embo J 22, 1381-1388.

 

H2AX  --- Valerie Morris

Celeste A et al. (2003) H2AX Haploinsufficiency modifies genomic stability and tumor susceptibility. Cell  114: 371-383.

 

 

FRIDAY, FEBRUARY 6, 2:30 PM

Session III

 

AID   ---  Eric Merkley

Chaudhuri, J., Tian, M., Khuong, C., Chua, K., Pinaud, E., and Alt, F. W. (2003). Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422, 726-730.

 

APOBECS   ---  Greg Brennan

Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. (2003). Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103.

 

 

Pol eta  --- Dan Gestaut

Zheng, H., Wang, X., Warren, A. J., Legerski, R. J., Nairn, R. S., Hamilton, J. W., and Li, L. (2003). Nucleotide excision repair- and polymerase eta-mediated error-prone removal of mitomycin C interstrand cross-links. Mol Cell Biol 23, 754-761.

 

Pol iota --- Cynthia Glover

Faili, A., Aoufouchi, S., Flatter, E., Gueranger, Q., Reynaud, C. A., and Weill, J. C. (2002). Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase iota. Nature 419, 944-947.

 

RAD51 Paralogues   --- Michelle Shimogawa

Liu, N., Schild, D., Thelen, M. P., and Thompson, L. H. (2002). Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells. Nucleic Acids Res 30, 1009-1015.

 

            RAD51C/XRCC3

Liu et al., 2004 --- Laura Sycuro

Liu, Y., Masson, J. Y., Shah, R., O'Regan, P., and West, S. C. (2004). RAD51C is required for Holliday junction processing in mammalian cells. Science 303, 243-246.

 

 

FRIDAY, FEBRUARY 6, 4:00 PM

Session IV

 

TFIIH --- Angela Shaulov

Dubaele, S., Proietti De Santis, L., Bienstock, R. J., Keriel, A., Stefanini, M., Van Houten, B., and Egly, J. M. (2003). Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy in XPD patients. Mol Cell 11, 1635-1646.

 

CSB  --- Vivian Hawkins

Osterod, M., Larsen, E., Le Page, F., Hengstler, J. G., Van Der Horst, G. T., Boiteux, S., Klungland, A., and Epe, B. (2002). A global DNA repair mechanism involving the Cockayne syndrome B (CSB) gene product can prevent the in vivo accumulation of endogenous oxidative DNA base damage. Oncogene 21, 8232-8239.

 

XPD  --- Johanna Eddy

de Boer, J., Andressoo, J. O., de Wit, J., Huijmans, J., Beems, R. B., van Steeg, H., Weeda, G., van der Horst, G. T., van Leeuwen, W., Themmen, A. P., et al. (2002). Premature aging in mice deficient in DNA repair and transcription. Science 296, 1276-1279.

 

ERCC1/XPF  --- Deidre L. Golej

Niedernhofer, L. J., Essers, J., Weeda, G., Beverloo, B., de Wit, J., Muijtjens, M., Odijk, H., Hoeijmakers, J. H., and Kanaar, R. (2001). The structure-specific endonuclease Ercc1-Xpf is required for targeted gene replacement in embryonic stem cells. Embo J 20, 6540-6549.

 

Ubiquitin, Sumo  --- Di Kim

Meetei, A. R., de Winter, J. P., Medhurst, A. L., Wallisch, M., Waisfisz, Q., van de Vrugt, H. J., Oostra, A. B., Yan, Z., Ling, C., Bishop, C. E., et al. (2003a). A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 35, 165-170.

 

ATM --- Eric Herbig

Bakkenist, C. J., and Kastan, M. B. (2003). DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499-506.

 

ATR --- Terri Sundsvold

Costanzo, V., Shechter, D., Lupardus, P. J., Cimprich, K. A., Gottesman, M., and Gautier, J. (2003). An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication. Mol Cell 11, 203-213.

 

P53  ---Ashok Bandaranayake

Zhu, C., Mills, K. D., Ferguson, D. O., Lee, C., Manis, J., Fleming, J., Gao, Y., Morton, C. C., and Alt, F. W. (2002). Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 109, 811-821.

 

HAPPY HOUR, 5:30 -----